NCT03148548View on ClinicalTrials.gov

Substudy - Evaluation of Patients With Iliac Vein Thrombosis

CompletedOBSERVATIONAL
Enrollment

85

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

January 31, 2018

Study Completion Date

January 31, 2018

Conditions
Iliac Vein Thrombosis
Interventions
GENETIC

thrombophilia screening

genetic Evaluation of Factor-V-Leiden, Factor-II\_G20210A Mutation;

Trial Locations (1)

60389

Cardioangiologisches Centrum Bethanien, Frankfurt am Main

All Listed Sponsors
lead

Cardioangiologisches Centrum Bethanien

OTHER

NCT03148548 - Substudy - Evaluation of Patients With Iliac Vein Thrombosis | Biotech Hunter | Biotech Hunter